Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 28, 2015; 21(40): 11396-11410
Published online Oct 28, 2015. doi: 10.3748/wjg.v21.i40.11396
Published online Oct 28, 2015. doi: 10.3748/wjg.v21.i40.11396
Figure 5 Experimental design for in vitro and in vivo studies and anti-MUC1 IgG antibody production assessed with an enzyme-linked immunosorbent assay.
A: Schematic illustration of the experimental protocol; B: Anti-MUC1 IgG production in knockout mice vaccinated with α-gal PANC1, and anti-MUC1 IgG production in knockout mice vaccinated with parental PANC1; C: Size of subcutaneous tumors after challenge with MUC1-B16F10 cells. +: Death.
- Citation: Tanemura M, Miyoshi E, Nagano H, Eguchi H, Matsunami K, Taniyama K, Hatanaka N, Akamatsu H, Mori M, Doki Y. Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction. World J Gastroenterol 2015; 21(40): 11396-11410
- URL: https://www.wjgnet.com/1007-9327/full/v21/i40/11396.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i40.11396